中国卒中杂志 ›› 2020, Vol. 15 ›› Issue (09): 934-941.DOI: 10.3969/j.issn.1673-5765.2020.09.003
刘慧慧,姜倩梅,戴婧,刘春风
收稿日期:
2020-06-30
出版日期:
2020-09-20
发布日期:
2020-09-20
通讯作者:
刘春风 liuchunfeng@suda.edu.cn
基金资助:
国家自然科学基金(81701149)
江苏省医学重点学科(ZDXKB2016022)
苏州市临床医学中心立项项目(Szzx201503)
Received:
2020-06-30
Online:
2020-09-20
Published:
2020-09-20
摘要:
随着静脉溶栓时间窗从3 h扩展到了9 h,研究重点也从时间窗理念扩展至组织窗理念。对 于发病时间不明、醒后卒中或者一定时间内的超时间窗患者,需完善相关神经影像学检查,权衡利弊 后决定是否静脉溶栓治疗。本文重点梳理了近年来根据组织窗寻找静脉溶栓获益患者的各种不同 筛选方法及静脉溶栓的药物选择,希望能为临床提供参考。
刘慧慧,姜倩梅,戴婧,刘春风. 急性缺血性卒中静脉溶栓治疗研究新进展[J]. 中国卒中杂志, 2020, 15(09): 934-941.
LIU Hui-Hui, JIANG Qian-Mei, DAI Jing,LIU Chun-Feng. Advances in Intravenous Thrombolysis for Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2020, 15(09): 934-941.
[1] GBD 2016 Stroke Collaborators. Global,regional,and national burden of stroke,1990-2016:asystematic analysis for the Global Burden of DiseaseStudy 2016[J]. Lancet Neurol,2019,18(5):439-458.[2] GBD 2016 Lifetime Risk of Stroke Collaborators,FEIGIN V L,NGUYEN G,et al. Global,regional,and country-specific lifetime risks of stroke,1990and 2016[J]. N Engl J Med,2018,379(25):2429-2437.[3] POWERS W J,RABINSTEIN A A,ACKERSONT,et al. Guidelines for the early management ofpatients with acute ischemic stroke:2019 updateto the 2018 guidelines for the early management ofacute ischemic stroke:a guideline for healthcareprofessionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2020-06-30]. https://doi.org/10.1161/STR.0000000000000211.[4] National Institute of Neurological Disordersand Stroke rt-PA Stroke Study Group. Tissueplasminogen activator for acute ischemic stroke[J/OL]. N Engl J Med,1995,333:1581-1587[2020-06-30]. https://doi.org/10.1056/NEJM199512143332401.[5] MA H,CAMPBELL B C V,PARSONS M W,etal. Thrombolysis guided by perfusion imaging up to9 hours after onset of stroke[J]. N Engl J Med,2019,380(19):1795-1803.[6] CAMPBELL B C V,MA H,RINGLEB P A,etal. Extending thrombolysis to 4.5-9 h and wake-upstroke using perfusion imaging:a systematic reviewand meta-analysis of individual patient data[J].Lancet,2019,394(10193):139-147.[7] LARRUE V,VON KUMMER R,DEL ZOPPO G,et al. Hemorrhagic transformation in acute ischemicstroke. Potential contributing factors in the EuropeanCooperative Acute Stroke Study[J]. Stroke,1997,28(5):957-960.[8] ASTRUP J,SIESJÖ B K,SYMON L. Thresholds incerebral ischemia - the ischemic penumbra[J]. Stroke,1981,12(6):723-725.[9] HEISS W D,ZARO WEBER O. Validationof MRI determination of the penumbra by PETmeasurements in ischemic stroke[J]. J Nucl Med,2017,58(2):187-193.[10] KIDWELL C S,ALGER J R,SAVER J L. Beyondmismatch:evolving paradigms in imaging theischemic penumbra with multimodal magneticresonance imaging[J]. Stroke,2003,34(11):2729-2735.[11] KONSTAS A A,LEV M H. CT perfusion imagingof acute stroke:the need for arrival time,delayinsensitive,and standardized postprocessingalgorithms?[J]. Radiology,2010,254(1):22-25.[12] CHUNG J W,KIM J Y,PARK H K,et al. Impact ofthe penumbral pattern on clinical outcome in patientswith successful endovascular revascularization[J]. JStroke Cerebrovasc Dis,2017,26(2):360-367.[13] CEREDA C W,CHRISTENSEN S,CAMPBELL BC V,et al. A benchmarking tool to evaluate computertomography perfusion infarct core predictionsagainst a DWI standard[J]. J Cereb Blood FlowMetab,2016,36(10):1780-1789.[14] CAMPBELL B C V,CHRISTENSEN S,LEVI C R,et al. Cerebral blood flow is the optimal CT perfusionparameter for assessing infarct core[J]. Stroke,2011,42(12):3435-3440.[15] BIVARD A,MCELDUFF P,SPRATT N,etal. Defining the extent of irreversible brainischemia using perfusion computed tomography[J].Cerebrovasc Dis,2011,31(3):238-245.[16] WU L,WU W,TALI E T,et al. Oligemia,penumbra,infarction:understanding hypoperfusionwith neuroimaging[J]. Neuroimaging Clin N Am,2018,28(4):599-609.[17] LIN L T,BIVARD A,KRISHNAMURTHY V,etal. Whole-brain CT perfusion to quantify acuteischemic penumbra and core[J]. Radiology,2016,279(3):876-887.[18] MARTINS N,AIRES A,MENDEZ B,et al. Ghostinfarct core and admission computed tomographyperfusion:redefining the role of neuroimaging inacute ischemic stroke[J]. Interventional neurology,2018,7(6):513-521.[19] BONED S,PADRONI M,RUBIERA M,et al.Admission CT perfusion may overestimate initialinfarct core:the ghost infarct core concept[J]. JNeurointerv Surg,2017,9(1):66-69.[20] GEUSKENS R R E G,BORST J,LUCASM,et al. Characteristics of misclassified CTperfusion ischemic core in patients with acuteischemic stroke[J/OL]. PLoS One,2015,10(11):e0141571[2020-06-30]. https://doi.org/10.1371/journal.pone.0141571.[21] VAGAL A,WINTERMARK M,NAEL K,et al.Automated CT perfusion imaging for acute ischemicstroke:pearls and pitfalls for real-world use[J].Neurology,2019,93(20):888-898.[22] KUDO K,SASAKI M,YAMADA K,et al.Differences in CT perfusion maps generated bydifferent commercial software:quantitative analysisby using identical source data of acute strokepatients[J]. Radiology,2010,254(1):200-209.[23] FAHMI F,MARQUERING H A,STREEKSTRA GJ,et al. Differences in CT perfusion summary mapsfor patients with acute ischemic stroke generated by2 software packages[J]. AJNR Am J Neuroradiol,2012,33(11):2074-2080.[24] GLE?A,CHRZAN R,URBANIK A. Theeffect of software post-processing applicationson identification of the penumbra and core withinthe ischaemic region in perfusion computedtomography[J/OL]. Pol J Radiol,2019,84:e118-e125[2020-06-30]. https://doi.org/10.5114/pjr.2019.83182.[25] MOKIN M,LEVY E I,SAVER J L,et al. Predictivevalue of RAPID assessed perfusion thresholds onfinal infarct volume in SWIFT PRIME(SolitaireWith the Intention for Thrombectomy as PrimaryEndovascular Treatment)[J]. Stroke,2017,48(4):932-938.[26] AUSTEIN F,RIEDEL C,KERBY T,et al.Comparison of perfusion CT software to predict thefinal infarct volume after thrombectomy[J]. Stroke,2016,47(9):2311-2317.[27] KUDO K,CHRISTENSEN S,SASAKI M,etal. Accuracy and reliability assessment of CT andMR perfusion analysis software using a digitalphantom[J]. Radiology,2013,267(1):201-211.[28] CHEN C S,BIVARD A,LIN L T,et al. Thresholdsfor infarction vary between gray matter and whitematter in acute ischemic stroke:a CT perfusionstudy[J]. J Cereb Blood Flow Metab,2019,39(3):536-546.[29] PALLESEN L P,GERBER J,DZIALOWSKI I,et al.Diagnostic and prognostic impact of pc-ASPECTSapplied to perfusion CT in the Basilar ArteryInternational Cooperation Study[J]. J Neuroimaging,2015,25(3):384-389.[30] SPORNS P,SCHMIDT R,MINNERUP J,etal. Computed tomography perfusion improvesdiagnostic accuracy in acute posterior circulationstroke[J]. Cerebrovasc Dis,2016,41(5/6):242-247.[31] VAN DER HOEVEN E J,DANKBAAR J W,ALGRA A,et al. Additional diagnostic value ofcomputed tomography perfusion for detection ofacute ischemic stroke in the posterior circulation[J].Stroke,2015,46(4):1113-1115.[32] SCHAEFER P W,GRANT P E,GONZALEZ RG. Diffusion-weighted MR imaging of the brain[J].Radiology,2000,217(2):331-345.[33] CAMPBELL B C V,PURUSHOTHAM A,CHRISTENSEN S,et al. The infarct core is wellrepresented by the acute diffusion lesion:sustainedreversal is infrequent[J]. J Cereb Blood Flow Metab,2012,32(1):50-56.[34] LABEYRIE M A,TURC G,HESS A,et al.Diffusion lesion reversal after thrombolysis:a MRcorrelate of early neurological improvement[J].Stroke,2012,43(11):2986-2991.[35] THOMALLA G,SIMONSEN C Z,BOUTITIEF,et al. MRI-guided thrombolysis for stroke withunknown time of onset[J]. N Engl J Med,2018,379(7):611-622.[36] BOUSLAMA M,BOWEN M T,HAUSSEN D C,etal. Selection paradigms for large vessel occlusionacute ischemic stroke endovascular therapy[J].Cerebrovasc Dis,2017,44(5/6):277-284.[37] CAMPBELL B C,MITCHELL P J,KLEINIG T J,et al. Endovascular therapy for ischemic stroke withperfusion-imaging selection[J]. N Engl J Med,2015,372(11):1009-1018.[38] SAVER J L,GOYAL M,BONAFE A,et al. Stent retriever thrombectomy after intravenous t-PA vs.t-PA alone in stroke[J]. N Engl J Med,2015,372(24):2285-2295.[39] ALBERS G W,MARKS M P,KEMP S,et al.Thrombectomy for stroke at 6 to 16 hours withselection by perfusion imaging[J]. N Engl J Med,2018,378(8):708-718.[40] RINGLEB P,BENDSZUS M,BLUHMKI E,etal. Extending the time window for intravenousthrombolysis in acute ischemic stroke using magneticresonance imaging-based patient selection[J]. Int JStroke,2019,14(5):483-490.[41] NOGUEIRA R G,JADHAV A P,HAUSSEN D C,et al. Thrombectomy 6 to 24 hours after stroke witha mismatch between deficit and infarct[J]. N Engl JMed,2018,378(1):11-21.[42] KOGA M,YAMAMOTO H,INOUE M,etal. Thrombolysis with alteplase at 0.6 mg/kg forstroke with unknown time of onset:a randomizedcontrolled trial[J]. Stroke,2020,51(5):1530-1538.[43] YU W G,JIANG W J. A simple imaging guide forendovascular thrombectomy in acute ischemic stroke:from time window to perfusion mismatch andbeyond[J/OL]. Front Neurol,2019,10:502[2020-06-30]. https://doi.org/10.3389/fneur.2019.00502.[44] KENT D M,HILL M D,RUTHAZER R,et al."Clinical-CT mismatch" and the response to systemicthrombolytic therapy in acute ischemic stroke[J].Stroke,2005,36(8):1695-1699.[45] MESSÉ S R,KASNER S E,CHALELA J A,et al.CT-NIHSS mismatch does not correlate with MRIdiffusion-perfusion mismatch[J]. Stroke,2007,38(7):2079-2084.[46] BONAVENTURA A,MONTECUCCO F,DALLEGRI F. Update on the effects of treatmentwith recombinant tissue-type plasminogen activator(rt-PA)in acute ischemic stroke[J]. Expert Opin BiolTher,2016,16(11):1323-1340.[47] LOGALLO N,KVISTAD C E,NACU A,et al.The Norwegian tenecteplase stroke trial(NORTEST):randomised controlled trial of tenecteplasevs. alteplase in acute ischaemic stroke[J/OL]. BMCNeurol,2014,14:106[2020-06-30]. https://doi.org/10.1186/1471-2377-14-106.[48] KVISTAD C E,NOVOTNY V,KURZ M W,et al.Safety and outcomes of tenecteplase in moderateand severe ischemic stroke[J]. Stroke,2019,50(5):1279-1281.[49] CAMPBELL B C,MITCHELL P J,CHURILOVL,et al. Tenecteplase versus alteplase beforeendovascular thrombectomy(EXTEND-IA TNK):a multicenter,randomized,controlled study[J]. Int JStroke,2018,13(3):328-334.[50] CAMPBELL B C V,MITCHELL P J,CHURILOVL,et al. Determining the optimal dose oftenecteplase before endovascular therapy forischemic stroke(EXTEND-IA TNK Part 2):amulticenter,randomized,controlled study[J]. Int JStroke,2019,15(5):567-572.[51] YANG P F,ZHANG Y W,ZHANG L,et al.Endovascular Thrombectomy with or withoutintravenous alteplase in acute stroke[J]. N Engl JMed,2020,382(21):1981-1993. |
[1] | 鲁燕, 杨保荣, 黄向萍, 杨冠桂, 陈圣文, 李建荣, 曾小明. 县级医院急性缺血性卒中超时间窗经MRI筛选溶栓的病例对照研究 [J]. 中国卒中杂志, 2022, 17(12): 1321-1326. |
[2] | 向薇, 徐璐瑶, 张曼曼, 魏红春, 梁志刚. 缺血性卒中急性期磁敏感加权成像不对称突出静脉征的发生率及影响因素分析[J]. 中国卒中杂志, 2022, 17(10): 1097-1102. |
[3] | 张伯煜, 郭玉成, 崔玉霞, 李英丽, 吕雨梅. 急性缺血性卒中患者就医行为决策现状及影响因素研究进展[J]. 中国卒中杂志, 2022, 17(10): 1127-1132. |
[4] | 吴亭亭, 刘亚飞, 闫世曦, 武一平, 张忠波, 张邯菲, 房娉平. “互联网+”在急性缺血性卒中救治中的应用进展[J]. 中国卒中杂志, 2022, 17(10): 1133-1138. |
[5] | 郑玮, 翟华筝, 陈萌萌, 汪敬业. 直接取栓与桥接治疗对急性大血管闭塞性缺血性卒中疗效比较的荟萃分析[J]. 中国卒中杂志, 2022, 17(07): 720-729. |
[6] | 周娟, 谭云宾, 王铁军, 石富铭, 余苹. 急性缺血性卒中患者住院期间照顾者焦虑抑郁的发生率及影响因素分析[J]. 中国卒中杂志, 2022, 17(07): 764-768. |
[7] | 玄桂英, 范彩丽, 玄丽霞, 赵倩倩, 李雪梅. 新型冠状病毒肺炎疫情期间急性缺血性卒中患者门诊随诊失访原因分析[J]. 中国卒中杂志, 2022, 17(06): 648-652. |
[8] | 张东, 李治璋, 马瑞楠, 岳蕴华. 应激性高血糖比值与急性缺血性卒中患者临床预后的相关性研究[J]. 中国卒中杂志, 2022, 17(05): 483-490. |
[9] | 黄妍, 付学军, 史会杰, 邹良玉. 三酰甘油-葡萄糖指数与急性缺血性卒中神经功能缺损的相关性分析[J]. 中国卒中杂志, 2022, 17(03): 251-257. |
[10] | 刘忠, 刘媛媛, 徐少峰, 郭伟, 康海. 系统免疫炎性指数与急性缺血性卒中严重程度及预后的相关性分析[J]. 中国卒中杂志, 2022, 17(03): 285-291. |
[11] | 李力卓, 胡悦, 何松柏, 杨玉瑶, 宋灏哲, 王勇, 李凤杰, 单志刚, 郭伟. 助力健康——移动卒中单元在行动[J]. 中国卒中杂志, 2022, 17(02): 107-111. |
[12] | 郭松韬, 额布, 李智强, 姜昊, 许玉柱, 孙舰, 史建民, 吴喜, 郭伟. 第五代移动通信技术移动卒中单元的研究进展[J]. 中国卒中杂志, 2022, 17(02): 113-117. |
[13] | 王拥军, 熊云云, 李子孝, 张玉梅, 杨晓萌, 王上, 霍晓川, 杨明, 谢雪微, 罗岗, 陈晓霖, 李光硕, 王利圆, 王传颖, 闫然, 王文洁, 段春苗, 路正钊. 卒中:回眸2021[J]. 中国卒中杂志, 2022, 17(01): 1-20. |
[14] | 霍晓川, 李晓青, 缪中荣, 国家神经系统疾病医疗质量控制中心神经介入质控专 家委员会, 急性脑梗死再灌注治疗质量改进国家行动血管内治疗工作委员会. 2020中国急性缺血性卒中血管内治疗现状调查分析[J]. 中国卒中杂志, 2022, 17(01): 56-65. |
[15] | 陈政宇, 陈国芳, 陈彤, 马冬娇. 急性缺血性卒中静脉溶栓患者不同部位脑白质疏松的影响因素分析[J]. 中国卒中杂志, 2021, 16(12): 1248-1252. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||